Pbx1	O
is	O
a	O
downstream	O
target	O
of	O
Evi	O
-	O
1	O
in	O
hematopoietic	B-Cell
stem	I-Cell
/	I-Cell
progenitors	I-Cell
and	O
leukemic	B-Cell
cells	I-Cell
.	O

Ecotropic	O
viral	O
integration	O
site	O
-	O
1	O
(	O
Evi	O
-	O
1	O
)	O
is	O
a	O
nuclear	B-Cellular_component
transcription	O
factor	O
,	O
which	O
is	O
essential	O
for	O
the	O
proliferation	O
/	O
maintenance	O
of	O
hematopoietic	B-Cell
stem	I-Cell
cells	I-Cell
(	O
HSCs	B-Cell
)	O
.	O

Aberrant	O
expression	O
of	O
Evi	O
-	O
1	O
has	O
been	O
frequently	O
found	O
in	O
myeloid	B-Cancer
leukemia	I-Cancer
,	O
and	O
is	O
associated	O
with	O
a	O
poor	O
patient	O
survival	O
.	O

Recently	O
,	O
we	O
reported	O
candidate	O
target	O
genes	O
of	O
Evi	O
-	O
1	O
shared	O
in	O
HSCs	B-Cell
and	O
leukemic	B-Cell
cells	I-Cell
using	O
gene	O
expression	O
profiling	O
analysis	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
Pbx1	O
,	O
a	O
proto	O
-	O
oncogene	O
in	O
hematopoietic	B-Pathological_formation
malignancy	I-Pathological_formation
,	O
as	O
a	O
target	O
gene	O
of	O
Evi	O
-	O
1	O
.	O

Overexpression	O
of	O
Evi	O
-	O
1	O
increased	O
Pbx1	O
expression	O
in	O
hematopoietic	B-Cell
stem	I-Cell
/	I-Cell
progenitor	I-Cell
cells	I-Cell
.	O

An	O
analysis	O
of	O
the	O
Pbx1	O
promoter	O
region	O
revealed	O
that	O
Evi	O
-	O
1	O
upregulates	O
Pbx1	O
transcription	O
.	O

Furthermore	O
,	O
reduction	O
of	O
Pbx1	O
levels	O
through	O
RNAi	O
-	O
mediated	O
knockdown	O
significantly	O
inhibited	O
Evi	O
-	O
1	O
-	O
induced	O
transformation	O
.	O

In	O
contrast	O
,	O
knockdown	O
of	O
Pbx1	O
did	O
not	O
impair	O
bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
transformation	O
by	O
E2A	O
/	O
HLF	O
or	O
AML1	O
/	O
ETO	O
,	O
suggesting	O
that	O
Pbx1	O
is	O
specifically	O
required	O
for	O
the	O
maintenance	O
of	O
bone	B-Multi-tissue_structure
marrow	I-Multi-tissue_structure
transformation	O
mediated	O
by	O
Evi	O
-	O
1	O
.	O

These	O
results	O
indicate	O
that	O
Pbx1	O
is	O
a	O
target	O
gene	O
of	O
Evi	O
-	O
1	O
involved	O
in	O
Evi	O
-	O
1	O
-	O
mediated	O
leukemogenesis	O
.	O

